Actithera is a radiopharmaceutical biotech company translating medicinal chemistry insights into next-generation radioligand therapies (RLTs). Founded in 2021 by drug discovery innovator Dr. Andreas Goutopoulos, and seed investors M Ventures, and Arkin Bio Ventures II, Actithera applies various molecular design strategies, including covalent-targeting and an isotope-agnostic philosophy to invent RLTs with significant differentiation and larger therapeutic windows. Headquartered in Oslo, Norway, and Cambridge, Massachusetts, Actithera is committed to advancing a differentiated pipeline addressing critical unmet needs in oncology.
| Website | https://actithera.com/ |
| Employees | 30 (10 on RocketReach) |
| Address | 1 Broadway 14th Floor, Cambridge, Massachusetts 02142, US |
| Industry | Biotechnology Research |
Looking for a particular Actithera employee's phone or email?
Actithera Questions
Andreas Goutopoulos is the CEO and Founder of Actithera.
10 people are employed at Actithera.
Actithera is based in Cambridge, Massachusetts.
Top Actithera Employees
-
Andreas Goutopoulos
CEO and Founder at Actithera
Boston, MA, US45+ -
Igor Mochalkin
VP, Discovery Technology at Actithera
Cambridge, MA, US24 -
Darshan Dalal
Chief Medical Officer at Actithera
New York, NY, US21 -
Hyelim Cho
VP, Head of Strategy at Actithera
Boston, MA, US1 -
44
-
Sarah Vanrenterghem
Head of Quality at Actithera
Wielsbeke, BE1 -
21
Related Companies
